Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07280715 · ClinicalTrials.gov registry record · NA

Investigating Real-Time Immunotherapy Symptoms Study

A NA study, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
40
Enrollment target

NCT07280715 is a NA study that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07280715, a NA study, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of this study is to evaluate the feasibility of using information from wearable devices and self-reported symptoms to remotely monitor patients during immunotherapy. The main questions it aims to answer are: * Is the digital remote patient monitoring tool feasible and acceptable to patients? * Do the alerts and guidance improve symptom management, quality of life, and engagement with the care team during treatment? Participants will: * Complete a demographic questionnaire at the beginning of the study and quality-of-life and health questionnaires at the beginning, midpoint, and end of study. * As feasible: At the beginning and end of the study, complete an in-person physical function assessment measuring balance (Short Physical Performance Battery). If participant is randomly assigned to the intervention group, they will also: * Complete weekly symptom ratings via digital remote patient monitoring tool * Wear a Fitbit activity tracker for 90 days. * At the end of the study, complete a semi-structured interview to provide feedback on the study.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Digital remote monitoring intervention

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-06-17
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT07280715

The ClinicalTrials.gov registry entry for NCT07280715 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT07280715 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07280715 about?

NCT07280715 is a clinical study titled "Investigating Real-Time Immunotherapy Symptoms Study". The goal of this study is to evaluate the feasibility of using information from wearable devices and self-reported symptoms to remotely monitor patients during immunotherapy. The main questions it aims to answer are: * Is the digital remote patient monitoring tool feasible and acceptable to patient...

What is the current status of trial NCT07280715?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06-17. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT07280715?

The interventions under investigation include: Usual Care (OTHER), Digital remote monitoring intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07280715?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.